SBI JI
Israelsbi-ji.co.il
Overview
SBI JI is a venture capital firm formed in 2017 as a partnership between Japan's SBI Holdings and Israel's Vertex Venture Capital. The firm initially focused on bio-investments and has since expanded to other high-tech sectors. It primarily invests in Israeli or Israel-related venture-backed companies across various development stages, with a tendency to enter at Series B. Its investment portfolio includes companies in Life Sciences, High Tech, and Enterprise Applications.
Portfolio Companies
2
Website
sbi-ji.co.ilInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Orasis Pharmaceuticals | Oct 2024 | Series D | Co-investor |
| Orasis Pharmaceuticals | Sep 2020 | Series C | Lead |
| Orasis Pharmaceuticals | Jun 2018 | Series B | Co-investor |
| Cylus | Jan 2018 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.